Evidence map›Paper›PMID 30408103›Full record

ArticlePloS one2018

Loss of CXCL12/CXCR4 signalling impacts several aspects of cardiovascular development but does not exacerbate Tbx1 haploinsufficiency.

Mahalia Page, Liam Ridge, Diana Gold Diaz, Tsolmon Tsogbayar, Peter J Scambler, Sarah Ivins

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in cell and developmental biology · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mahalia PageDevelopmental Biology of Birth Defects, UCL Institute of Child Health, London, United Kingdom.
Liam RidgeDevelopmental Biology of Birth Defects, UCL Institute of Child Health, London, United Kingdom.
Diana Gold DiazDevelopmental Biology of Birth Defects, UCL Institute of Child Health, London, United Kingdom.
Tsolmon TsogbayarDevelopmental Biology of Birth Defects, UCL Institute of Child Health, London, United Kingdom.
Peter J ScamblerDevelopmental Biology of Birth Defects, UCL Institute of Child Health, London, United Kingdom.
Sarah IvinsDevelopmental Biology of Birth Defects, UCL Institute of Child Health, London, United Kingdom.ORCID 0000-0002-9216-4859
University College London · GB

Funding

ENDOCYTOSIS IN CAPILLARY ENDOTHELIUMK04HL001514 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI WILLIAMS, STUART K · 1985 to 1989
–
British Heart Foundation PG/14/35/30837British Heart Foundation RG/15/14/31880
6 · The paper itself

Abstract

The CXCL12-CXCR4 pathway has crucial roles in stem cell homing and maintenance, neuronal guidance, cancer progression, inflammation, remote-conditioning, cell migration and development. Recently, work in chick suggested that signalling via CXCR4 in neural crest cells (NCCs) has a role in the 22q11.2 deletion syndrome (22q11.2DS), a disorder where haploinsufficiency of the transcription factor TBX1 is responsible for the major structural defects. We tested this idea in mouse models. Our analysis of genes with altered expression in Tbx1 mutant mouse models showed down-regulation of Cxcl12 in pharyngeal surface ectoderm and rostral mesoderm, both tissues with the potential to signal to migrating NCCs. Conditional mutagenesis of Tbx1 in the pharyngeal surface ectoderm is associated with hypo/aplasia of the 4th pharyngeal arch artery (PAA) and interruption of the aortic arch type B (IAA-B), the cardiovascular defect most typical of 22q11.2DS. We therefore analysed constitutive mouse mutants of the ligand (CXCL12) and receptor (CXCR4) components of the pathway, in addition to ectodermal conditionals of Cxcl12 and NCC conditionals of Cxcr4. However, none of these typical 22q11.2DS features were detected in constitutively or conditionally mutant embryos. Instead, duplicated carotid arteries were observed, a phenotype recapitulated in Tie-2Cre (endothelial) conditional knock outs of Cxcr4. Previous studies have demonstrated genetic interaction between signalling pathways and Tbx1 haploinsufficiency e.g. FGF, WNT, SMAD-dependent. We therefore tested for possible epistasis between Tbx1 and the CXCL12 signalling axis by examining Tbx1 and Cxcl12 double heterozygotes as well as Tbx1/Cxcl12/Cxcr4 triple heterozygotes, but failed to identify any exacerbation of the Tbx1 haploinsufficient arch artery phenotype. We conclude that CXCL12 signalling via NCC/CXCR4 has no major role in the genesis of the Tbx1 loss of function phenotype. Instead, the pathway has a distinct effect on remodelling of head vessels and interventricular septation mediated via CXCL12 signalling from the pharyngeal surface ectoderm and second heart field to endothelial cells.

Indexed as

AnimalsAorta, ThoracicCardiovascular AbnormalitiesCardiovascular SystemChemokine CXCL12DiGeorge SyndromeDisease Models, AnimalEpistasis, GeneticFemaleHaploinsufficiencyHumansMaleMiceMice, Inbred C57BLMice, KnockoutMutationChemokine CXCL12Cxcl12 protein, mouseCXCR4 protein, mouseReceptors, CXCR4T-Box Domain ProteinsTbx1 protein, mouse

Identifiers

PMID30408103
PMCPMC6224166
OpenAlexW2899618557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.